TARSONSNSETarsons Products LimitedLowNeutral
Announced Sat, 30 Aug · 13:33 IST

Tarsons Products Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 22, 2025

Board & Shareholder Meetings View source PDF

TARSONS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Tarsons Products Limited has issued the notice for its 42nd Annual General Meeting (AGM) scheduled for Monday, September 22, 2025 at 12:00 PM IST, to be held via video conferencing. Ordinary business includes adoption of audited standalone and consolidated financial statements for FY ended March 31, 2025, and the re-appointment of Mr. Aryan Sehgal who retires by rotation. Special business covers the appointment of M/s. Manisha Saraf & Associates as Secretarial Auditors for five years (FY 2025-26 to 2029-30) at ₹75,000 plus taxes per year, appointment of Dr. Monjori Mitra as Independent Director for five years, appointment of Mr. Ramanathan Subramanian Arun Kumar (nominated by Clear Vision Investment Holdings Pte. Limited) as Non-Executive Nominee Director, and appointment of Mr. Suresh Eshwara Prabhala as Non-Executive Non-Independent Director for five years. Shareholders will also be asked to ratify a waiver of excess managerial remuneration of ₹9.38 million to CMD Mr. Sanjive Sehgal and ₹4.38 million to WTD Mr. Aryan Sehgal for FY 2024-25, and approve a revision in their remuneration effective September 1, 2025. E-voting runs from September 19-21, 2025, with a cut-off date of September 12, 2025.

Likely market impact

This is a routine procedural AGM notice. The most material item for shareholders is the ratification of excess remuneration paid to the CMD and WTD (totaling ₹13.76 million), which suggests the company's profits fell below statutory thresholds to justify the payouts—an indicator worth monitoring. The proposed director appointments and the executive pay revision are governance items that may marginally affect future expenses but are unlikely to cause an immediate share price reaction.